Beam Therapeutics

Compliant

Under AAOIFI Standard 21, Beam Therapeutics is compliant. Its core business is permissible and its interest-bearing debt is below 30% of market cap.

TickerBEAM

ExchangeNASDAQ

SectorBiotech

Full ratios for Beam Therapeutics (impure revenue, debt and interest-bearing deposits under all four standards) are being added. Until then this page shows the screening verdict only. See the methodology for how each test works. Purindex publishes this screening to help people understand what they own. It does not recommend buying, selling or holding Beam Therapeutics or any other security.